1 – 10 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Amplification of ERBB2 (HER2) in embryonal rhabdomyosarcoma : A potential treatment target in rare cases?
(
- Contribution to journal › Article
- 2018
-
Mark
Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Neuroblastoma with flat genomic profile : A question of representativity?
(
- Contribution to journal › Article
-
Mark
Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Genetic heterogeneity in rhabdomyosarcoma revealed by SNP array analysis.
(
- Contribution to journal › Article
-
Mark
Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours
(
- Contribution to journal › Article
- 2015
-
Mark
Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer.
(
- Contribution to journal › Article
-
Mark
Activation of human telomerase reverse transcriptase through gene fusion in clear cell sarcoma of the kidney.
(
- Contribution to journal › Article
-
Mark
Neuroblastoma Patient-Derived Orthotopic Xenografts Retain Metastatic Patterns and Geno- and Phenotypes of Patient Tumours.
(
- Contribution to journal › Article
- 2013
-
Mark
Intratumour diversity of chromosome copy numbers in neuroblastoma mediated by on-going chromosome loss from a polyploid state.
(
- Contribution to journal › Article